Back
Immuneering Corp. 10K Form
Sell
25
IMRX
Immuneering Corp.
Last Price:
$6.40
Seasonality Move:
-21.18%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive IMRX News And Ratings
See the #1 stock for the next 7 days that we like better than IMRX
IMRX Financial Statistics
Sales & Book Value
| Annual Sales: | $0 |
|---|---|
| Cash Flow: | $-12M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $3.59 |
| Price / Book: | 1.81 |
Profitability
| EPS (TTM): | -1.78320 |
|---|---|
| Net Income (TTM): | $-62.5M |
| Gross Margin: | $-713.5K |
| Return on Equity: | -78.54% |
| Return on Assets: | -68.97% |
Immuneering Corp. Earnings Forecast
Key Immuneering Corp. Financial Ratios
-
Per Share Earnings over the last 6 years have been positive in 1 years.
Immuneering Corp. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | IMRX |
| Website: | immuneering.com |
Debt
| Debt-to-Equity Ratio: | 0.02 |
|---|---|
| Current Ratio: | 24 |
| Quick Ratio: | 23.84 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
IMRX Technical Analysis vs Fundamental Analysis
Sell
25
Immuneering Corp. (IMRX)
is a Sell
Is Immuneering Corp. a Buy or a Sell?
-
Immuneering Corp. stock is rated a SellThe current Immuneering Corp. [IMRX] share price is $6.40. The Score for IMRX is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.